No abstract available
MeSH terms
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Benzamides / administration & dosage
-
Benzamides / adverse effects*
-
Disease Progression
-
Drug Administration Schedule
-
Female
-
Gastrointestinal Neoplasms / diagnosis
-
Gastrointestinal Neoplasms / drug therapy*
-
Gastrointestinal Neoplasms / pathology
-
Gastrointestinal Stromal Tumors / diagnosis
-
Gastrointestinal Stromal Tumors / drug therapy*
-
Gastrointestinal Stromal Tumors / secondary
-
Humans
-
Imatinib Mesylate
-
Incidental Findings
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / secondary
-
Middle Aged
-
Osteonecrosis / chemically induced*
-
Osteonecrosis / complications
-
Pain / etiology
-
Peritoneal Neoplasms / drug therapy*
-
Peritoneal Neoplasms / secondary
-
Piperazines / administration & dosage
-
Piperazines / adverse effects*
-
Protein Kinase Inhibitors / administration & dosage
-
Protein Kinase Inhibitors / adverse effects*
-
Pyrimidines / administration & dosage
-
Pyrimidines / adverse effects*
-
Range of Motion, Articular
-
Tibia / drug effects*
-
Tibia / pathology
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Protein Kinase Inhibitors
-
Pyrimidines
-
Imatinib Mesylate